Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus
The lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) can be proteolytically cleaved and released as soluble forms (sLOX-1). We have determined serums LOX-1 in type 2 diabetes and evaluated the effect of glucose and advanced glycation end products (AGEs) on sLOX-1 in vitro and in vivo....
Main Authors: | Kathryn C.B. Tan, Sammy W.M. Shiu, Ying Wong, Lin Leng, Richard Bucala |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2008-07-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520347155 |
Similar Items
-
Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer
by: Yu Peng, et al.
Published: (2022-12-01) -
Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study
by: Shou-En Wu, et al.
Published: (2021-10-01) -
Receptor of advanced glycation end products and cardiovascular risk in elderly with type 2 diabetes mellitus
by: Claudia Borsa, et al.
Published: (2018-02-01) -
Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality
by: Cheng YZ, et al.
Published: (2014-11-01) -
Advanced glycation end-products and its soluble receptor are not independent predictors of incident dysglycaemia or metabolic syndrome in women with polycystic ovary syndrome: a prospective observational study
by: Yu Wing Tong, et al.
Published: (2023-05-01)